COVID-19
GSK and Sanofi to begin new Phase II trial of their COVID-19 vaccine
February 22, 2021Sales and Marketing COVID, COVID Vaccine, COVID-19, GSK, Sanofi
GlaxoSmithKline (GSK) and Sanofi are set to begin a new Phase II study of their COVID-19 vaccine candidate, following setbacks …
Pharmafile.com’s top 10 news stories of the week
February 19, 2021Medical Communications COVID-19, COVID-19 vaccine, Vaccine, pharma news, top 10, top news stories
In the last week, a number of COVID-19 new vaccine developments have been made. Pfizer and BioNTech’s vaccine has proven …
Pharmafile.com’s weekly COVID-19 news round-up
February 17, 2021Research and Development COVID-19, COVID-19 vaccine, Vaccine, World Health Organisation, covid-19 roundup
The past week has continued to see positive COVID-19 vaccine news; a WHO panel approved the Oxford-AstraZeneca vaccine for all …
J&J’s one-shot COVID-19 vaccine submitted to the EU
February 17, 2021Research and Development COVID, COVID Vaccine, COVID-19, Johnson & Johnson, Vaccine
Johnson & Johnson has applied to the EMA for marketing authorisation of their one-shot COVID-19 vaccine in Europe.
North Korea accused of attempted Pfizer hack to steal COVID-19 vaccine data
February 16, 2021Manufacturing and Production COVID, COVID Vaccine, COVID-19, North Korea, Pfizer, Pfizer vaccine, Vaccine
North Korea has tried to hack into Pfizer’s servers in order to ascertain its COVID-19 vaccine technology, according to a …
South Korea orders 46 million more Novavax and Pfizer COVID-19 vaccines
February 16, 2021Manufacturing and Production COVID, COVID-19, Novavax, Pfizer, Vaccine, south korea
South Korea has arranged deals with Novavax and Pfizer-BioNTech to buy enough COVID-19 vaccines for 23 million more people.
WHO approves two versions of AstraZeneca’s COVID-19 vaccine
February 16, 2021Manufacturing and Production AstraZeneca, COVID-19, WHO
The WHO has greenlighted two versions of the Oxford-AstraZeneca COVID-19 vaccine for emergency use, granting them authorisation to be rolled …
Pfizer COVID-19 vaccine proven 94% effective in biggest study yet
February 15, 2021Sales and Marketing COVID-19, Pfizer, Pfizer vaccine, Vaccine, coronavirus
The Pfizer-BioNTech COVID-19 vaccine has been proven to be 94% effective, according to the first major study to evaluate the …
AstraZeneca’s COVID-19 vaccine to be trialled in children
February 15, 2021Sales and Marketing AstraZeneca, COVID-19
The Oxford-AstraZeneca COVID-19 vaccine is to be tested on children in the UK in a new trial commencing this month. …
AstraZeneca COVID-19 vaccine still restricted, despite WHO assurances
February 12, 2021Medical Communications AstraZeneca, COVID-19
Several European countries have continued to impose age restrictions on their rollouts of the Oxford University-AstraZeneca vaccine, despite WHO’s repeated …
Arthritis drug tocilizumab cuts COVID-19 deaths in hospital trial
February 12, 2021Medical Communications COVID-19
The rheumatoid arthritis drug tocilizumab can reduce the risk of death in severe COVID-19 patients and shorten the time spent …
FDA grants emergency authorisation to Lilly’s COVID-19 antibody combination
February 11, 2021COVID-19, Eli Lilly
The FDA has granted emergency use authorisation for Eli Lilly’s antibodies bamlanivimab (LY-CoV555) 700mg and etesevimab (LY-CoV016) 1400mg, to be …
WHO panel recommends AstraZeneca COVID-19 vaccine for over-65s
February 11, 2021AstraZeneca, COVID-19, WHO
Scientists advising the WHO have recommended the use of the Oxford-AstraZeneca COVID-19 vaccine in all adults, including those aged over …
Pharmafile.com’s weekly COVID-19 news round-up
February 10, 2021Research and Development COVID-19
The past week has seen lots of positive COVID-19 vaccine news; Oxford University and AstraZeneca have announced development of another …
South Korea approves AstraZeneca COVID-19 vaccine for use
February 10, 2021Research and Development AstraZeneca, COVID-19
South Korea is to grant first approval for the Oxford University-AstraZeneca vaccine later today, with the rollout expected to start …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
